1. Home
  2. ANL vs FMNB Comparison

ANL vs FMNB Comparison

Compare ANL & FMNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

HOLD

Current Price

$15.11

Market Cap

998.8M

Sector

N/A

ML Signal

HOLD

Logo Farmers National Banc Corp.

FMNB

Farmers National Banc Corp.

SELL

Current Price

$15.30

Market Cap

857.4M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
ANL
FMNB
Founded
2004
1887
Country
Singapore
United States
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
998.8M
857.4M
IPO Year
2022
2010

Fundamental Metrics

Financial Performance
Metric
ANL
FMNB
Price
$15.11
$15.30
Analyst Decision
Strong Buy
Buy
Analyst Count
7
3
Target Price
★ $29.50
$17.00
AVG Volume (30 Days)
143.5K
★ 320.4K
Earning Date
08-14-2026
10-21-2026
Dividend Yield
N/A
★ 4.69%
EPS Growth
N/A
★ 18.85
EPS
N/A
★ 0.76
Revenue
N/A
★ $279,922,000.00
Revenue This Year
$243.83
$39.49
Revenue Next Year
N/A
$7.45
P/E Ratio
★ N/A
$19.93
Revenue Growth
N/A
★ 3.89
52 Week Low
$0.88
$12.23
52 Week High
$17.25
$16.46

Technical Indicators

Market Signals
Indicator
ANL
FMNB
Relative Strength Index (RSI) 50.08 45.81
Support Level $14.70 $13.75
Resistance Level $15.29 $16.15
Average True Range (ATR) 1.02 0.26
MACD -0.11 -0.04
Stochastic Oscillator 29.50 42.86

Price Performance

Historical Comparison
ANL
FMNB

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.

About FMNB Farmers National Banc Corp.

Farmers National Banc Corp is a financial holding company based in the U.S. Along with its subsidiaries, it operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The group offers a full range of commercial and retail banking services, including checking accounts, savings accounts, time deposit accounts, commercial, mortgage, and installment loans, safe deposit boxes, ATMs, internet banking, and other banking services. Additionally, it offers personal and corporate trust services in the areas of estate settlement, trust administration, employee benefit plans, and retirement services; insurance products, and other financial products and services. The group's reportable segments are Bank, which generates the maximum revenue, and Trust.

Share on Social Networks: